These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 227624)

  • 81. [Surgical correction of hyperlipoproteinemia in patients with ischemic heart disease].
    Klimov AN; Lebedev LV; Sedletskiĭ IuI; Triufanov VF; Nagornev VA
    Kardiologiia; 1984 Feb; 24(2):21-4. PubMed ID: 6585597
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Fenofibrate therapy of hyperlipoproteinaemia. A dose-response study and a comparison with clofibrate.
    Rössner S; Orö L
    Atherosclerosis; 1981; 38(3-4):273-82. PubMed ID: 7225166
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Gemfibrozil: effect on serum lipids, lipoproteins, postheparin plasma lipase activities and glucose tolerance in primary hypertriglyceridaemia.
    Nikkilä EA; Ylikahri R; Huttunen JK
    Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):58-63. PubMed ID: 190608
    [TBL] [Abstract][Full Text] [Related]  

  • 84. [Lipoproteins and arteriosclerosis].
    Shinomiya M; Morisaki N; Murano S; Sasaki N; Shirai K; Matsuoka N; Saito Y; Kumagai A
    Nihon Rinsho; 1980 Jul; 38(7):2798-814. PubMed ID: 7007691
    [No Abstract]   [Full Text] [Related]  

  • 85. Recent progress in the development of radioimmunoassays for human serum lipoproteins.
    Karlin JB; Juhn DJ; Goldberg R; Rubenstein AH
    Ann Clin Lab Sci; 1978; 8(2):142-54. PubMed ID: 205163
    [TBL] [Abstract][Full Text] [Related]  

  • 86. The influence of continuous ambulatory peritoneal dialysis on plasma lipoproteins.
    Breckenridge WC; Roncari DA; Khanna R; Oreopoulos DG
    Atherosclerosis; 1982 Dec; 45(3):249-58. PubMed ID: 6961923
    [No Abstract]   [Full Text] [Related]  

  • 87. [On the effect of etofylline clofibrate on serum lipids and lipoproteins in patients with hyperlipoproteinemia of various degrees (author's transl)].
    Schneider J; Mühlfellner G; Mühlfellner O; Hausmann L; Schubotz R
    Arzneimittelforschung; 1980; 30(11b):2059-62. PubMed ID: 7194060
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Cholesterol, triglyceride, and lipoprotein studies: strategies for clinical use.
    Burke MD
    Postgrad Med; 1980 Mar; 67(3):263-6, 269, 273. PubMed ID: 7355139
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Correlations between intravenous fat tolerance and serum lipoproteins in normal and atherosclerotic subjects.
    Ericsson M; Rössner S
    Atherosclerosis; 1979 May; 33(1):89-97. PubMed ID: 223603
    [No Abstract]   [Full Text] [Related]  

  • 90. Double-blind comparison of bezafibrate versus placebo in male volunteers with hyperlipoproteinemia.
    Bradford RH; Goldberg AC; Schonfeld G; Knopp RH
    Atherosclerosis; 1992 Jan; 92(1):31-40. PubMed ID: 1575820
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Studies in asymptomatic primary hyperlipidaemia. V. Peripheral circulation.
    Olsson AG; Eklund B
    Acta Med Scand; 1975 Sep; 198(3):197-206. PubMed ID: 170797
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Proton magnetic resonance spectroscopy of fractionated plasma lipoproteins and reconstituted plasma from healthy subjects and patients with cancer.
    Engan T; Bjerve KS; Høe AL; Krane J
    Scand J Clin Lab Invest; 1992 Sep; 52(5):393-408. PubMed ID: 1514018
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Hyperapobetalipoproteinemia. Plasma lipoprotein responses to oral fat load.
    Genest J; Sniderman A; Cianflone K; Teng B; Wacholder S; Marcel Y; Kwiterovich P
    Arteriosclerosis; 1986; 6(3):297-304. PubMed ID: 3707428
    [TBL] [Abstract][Full Text] [Related]  

  • 94. "Sinking" lipoprotein in normal, hyperlipoproteinaemic and atherosclerotic patients.
    Avogaro PA; Cazzolato G
    Clin Chim Acta; 1975 Jun; 61(3):239-46. PubMed ID: 168007
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Hyperlipidemia in the Pacific Northwest Bell Telephone Company Health Survey. Part 2. Lipoprotein lipid interrelationships.
    Walden CE; Knopp RH; Wahl PW; Hoover JJ; Albers JJ; Hazzard WR; Ogilvie JT; Warnick GR
    Arteriosclerosis; 1983; 3(2):125-31. PubMed ID: 6573160
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Evaluation of a method for quantitative serum lipoprotein analysis.
    Parra H; Daunizeau A; Puchois P; Vanhoutte G; Fruchart JC
    Ric Clin Lab; 1982; 12(1):173-80. PubMed ID: 7089425
    [No Abstract]   [Full Text] [Related]  

  • 97. Plasma lipid and lipoprotein concentrations in an Egyptian male sample.
    Shoukry MI; Fareed S
    Lipids; 1982 Oct; 17(10):692-5. PubMed ID: 7176826
    [TBL] [Abstract][Full Text] [Related]  

  • 98. David Rubinstein Memorial Lecture: the biochemical and clinical significance of the interrelationship between very low density and high density lipoproteins.
    Alaupovic P
    Can J Biochem; 1981 Aug; 59(8):565-79. PubMed ID: 7028220
    [No Abstract]   [Full Text] [Related]  

  • 99. Increased amounts of cholesterol precursors in lipoproteins after ileal exclusion.
    Koivisto PV; Miettinen TA
    Lipids; 1988 Oct; 23(10):993-6. PubMed ID: 3200122
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Long-term effects of fenofibrate on serum lipids and on lipoprotein cholesterol in type II hyperlipoproteinemic patients.
    Sommariva D; Bonfiglioli D; Pogliaghi I; Cabrini E; Fasoli A
    Pharmacol Res Commun; 1984 Aug; 16(8):809-20. PubMed ID: 6593751
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.